Metoclopramide (Reglan) and Ketamine Therapy | Tovani Health
Reglan (Metoclopramide) — Dopamine D2 antagonist (prokinetic / antiemetic)
Verdict at Tovani Health
Compatible with KAP; the EPS / tardive dyskinesia concern is medication-intrinsic, not a KAP interaction.
Metoclopramide and ketamine have no clinically significant interaction. The well-known metoclopramide concerns (acute dystonia, akathisia, tardive dyskinesia with chronic use) are intrinsic to the medication and unchanged by KAP. Continue as prescribed and tell us about any movement-disorder symptoms at intake.
If you take Reglan regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Reglan interacts with ketamine
Metoclopramide is a D2 receptor antagonist that promotes gastric emptying and prevents nausea. Central D2 blockade is what drives the EPS risk. Ketamine adds sedation but does not change the EPS profile.
What we do at intake
Disclose dose, indication, and duration of therapy. If you have been on chronic metoclopramide and notice any movement-disorder symptoms, tell us before the session.
Bottom line
Metoclopramide and ketamine have no clinically significant interaction. The well-known metoclopramide concerns (acute dystonia, akathisia, tardive dyskinesia with chronic use) are intrinsic to the medication and unchanged by KAP. Continue as prescribed and tell us about any movement-disorder symptoms at intake.
Frequently Asked Questions
Is metoclopramide my best option for ketamine-related nausea?
Usually no. Ondansetron has a cleaner side-effect profile and is what we typically reach for first.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Reglan (Metoclopramide) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI.. Clinical Pharmacokinetics. 2016. PMID: 27028535
Comprehensive clinical pharmacokinetics/pharmacodynamics review of ketamine including CYP-mediated drug interactions (CYP3A4, CYP2B6).
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 16, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.